Decoy Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
Decoy Therapeutics Inc. (DCOY) reported Basic Shares Outstanding (Weighted Average) of 531.97 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 531.97K shares, a 4410.50% increase year-over-year.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 531.97K shares, a 7370.41% increase year-over-year.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -352.36K shares, a 319.59% decline year-over-year.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 481.59K shares, a 463.54% increase year-over-year.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 96.97K shares, a 20.93% increase from fiscal 2024.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 80.18K shares, a 80.35% decline from fiscal 2023.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 408.08K shares, a 80.79% decline from fiscal 2022.
- Decoy Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 2.12M shares, a 28.40% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 531.97K shares 10-Q · filed 2026-08-12 | 531.97K shares 10-Q · filed 2026-08-12 | 237.19K shares derived: average of 3 quarters · filed 2026-08-12 | 298.29K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 531.97K shares 10-Q · filed 2026-05-08 | 89.81K shares derived: average of 2 quarters · filed 2026-05-08 | 220.40K shares derived: average of 3 quarters · filed 2026-05-08 | 168.25K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -352.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 64.62K shares derived: average of 2 quarters · filed 2026-03-31 | 47.01K shares derived: average of 3 quarters · filed 2026-08-12 | 96.97K shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 481.59K shares 10-Q · filed 2025-11-14 | 246.69K shares derived: average of 2 quarters · filed 2026-08-12 | 246.74K shares 10-Q · filed 2025-11-14 | 165.24K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 11.79K shares 10-Q · filed 2026-08-12 | 2.12M shares 10-Q · filed 2025-08-12 | 10.51K shares 10-Q · filed 2026-08-12 | 1.89M shares 10-Q · filed 2025-08-12 | 59.79K shares derived: average of 3 quarters · filed 2026-08-12 | 66.21K shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | 7.12K shares 10-Q · filed 2026-05-08 | 1.66M shares 10-Q · filed 2025-05-14 | 83.79K shares derived: average of 2 quarters · filed 2026-05-08 | 84.35K shares derived: average of 3 quarters · filed 2026-05-08 | 213.36K shares derived: average of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | 160.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 122.96K shares derived: average of 2 quarters · filed 2026-03-31 | 282.11K shares derived: average of 3 quarters · filed 2026-03-31 | 80.18K shares 10-K · filed 2026-03-31 | 962.21K shares 10-K · filed 2025-03-21 | |||
| 2024-09-30 | 85.46K shares 10-Q · filed 2025-11-14 | 1.28M shares 10-Q · filed 2024-11-14 | 342.94K shares derived: average of 2 quarters · filed 2025-11-14 | 53.43K shares 10-Q · filed 2025-11-14 | 801.39K shares 10-Q · filed 2024-11-14 | 425.86K shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 600.42K shares 10-Q · filed 2025-08-12 | 558.52K shares 10-Q · filed 2025-08-12 | 539.33K shares derived: average of 3 quarters · filed 2025-08-12 | 521.81K shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 524.33K shares 10-Q · filed 2025-05-14 | 4.19M shares 10-Q · filed 2024-05-13 | 508.78K shares derived: average of 2 quarters · filed 2025-05-14 | 495.60K shares derived: average of 3 quarters · filed 2025-05-14 | 456.36K shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 493.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 481.24K shares derived: average of 2 quarters · filed 2025-03-21 | 433.71K shares derived: average of 3 quarters · filed 2025-03-21 | 408.08K shares 10-K · filed 2025-03-21 | 3.26M shares 10-K · filed 2024-03-22 | |||
| 2023-09-30 | 469.25K shares 10-Q · filed 2024-11-14 | 3.75M shares 10-Q · filed 2023-11-09 | 403.95K shares derived: average of 2 quarters · filed 2024-11-14 | 379.69K shares 10-Q · filed 2024-11-14 | 3.04M shares 10-Q · filed 2023-11-09 | 1.36M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 338.64K shares 10-Q · filed 2024-08-09 | 2.71M shares 10-Q · filed 2023-08-10 | 333.89K shares 10-Q · filed 2024-08-09 | 2.67M shares 10-Q · filed 2023-08-10 | 1.66M shares derived: average of 3 quarters · filed 2024-08-09 | 1.81M shares derived: average of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 2.39M shares 10-Q · filed 2024-05-13 | 2.32M shares derived: average of 2 quarters · filed 2024-05-13 | 2.30M shares derived: average of 3 quarters · filed 2024-05-13 | 2.26M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 2.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | 2.25M shares derived: average of 2 quarters · filed 2024-03-22 | 2.21M shares derived: average of 3 quarters · filed 2024-03-22 | 2.12M shares 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | 2.25M shares 10-Q · filed 2023-11-09 | 2.19M shares derived: average of 2 quarters · filed 2023-11-09 | 2.08M shares 10-Q · filed 2023-11-09 | 2.01M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 2.14M shares 10-Q · filed 2023-08-10 | 53.52M shares 10-Q · filed 2022-08-05 | 2.00M shares 10-Q · filed 2023-08-10 | 49.91M shares 10-Q · filed 2022-08-05 | 1.93M shares derived: average of 3 quarters · filed 2023-08-10 | 1.90M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 1.85M shares 10-Q · filed 2023-05-11 | 46.26M shares 10-Q · filed 2022-05-12 | 1.83M shares derived: average of 2 quarters · filed 2023-05-11 | 1.82M shares derived: average of 3 quarters · filed 2023-05-11 | 12.55M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | 1.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 1.80M shares derived: average of 2 quarters · filed 2023-03-27 | 16.12M shares derived: average of 3 quarters · filed 2023-03-27 | 1.65M shares 10-K · filed 2023-03-27 | 41.37M shares 10-K · filed 2022-03-25 | |||
| 2021-09-30 | 1.79M shares 10-Q · filed 2022-11-10 | 44.80M shares 10-Q · filed 2021-11-04 | 23.27M shares derived: average of 2 quarters · filed 2022-11-10 | 1.60M shares 10-Q · filed 2022-11-10 | 40.06M shares 10-Q · filed 2021-11-04 | 24.48M shares derived: average of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | 44.76M shares 10-Q · filed 2022-08-05 | 37.65M shares 10-Q · filed 2022-08-05 | 32.04M shares derived: average of 3 quarters · filed 2022-08-05 | 28.52M shares derived: average of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | 30.55M shares 10-Q · filed 2022-05-12 | 25.68M shares derived: average of 2 quarters · filed 2022-05-12 | 23.11M shares derived: average of 3 quarters · filed 2022-05-12 | 20.82M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | 20.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 19.39M shares derived: average of 2 quarters · filed 2022-03-25 | 17.58M shares derived: average of 3 quarters · filed 2022-03-25 | 15.58M shares 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | 17.97M shares 10-Q · filed 2021-11-04 | 15.96M shares derived: average of 2 quarters · filed 2021-11-04 | 13.83M shares 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | 13.95M shares 10-Q · filed 2021-08-05 | 11.74M shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |